Review Article
Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects
Table 2
Comparison of propofol and fospropofol characteristics according to [
14,
26–
29].
| Characteristics | Propofol | Fospropofol |
| Standard dose to induce general anesthesia | 1.5–2.5 mg/kg (lipid emulsion formulation) | 6.5 mg/kg (aqueous formulation) | Onset of action | 40 s–1 min (“one arm-brain circulation”) | 4–8 min | Duration of action after bolus dose | 3–10 min | 5–18 min | Volume of distribution (L/kg) | 5.8 | 0.3 | Total body clearance (L/h/kg) | 3.2 | 0.36 | Terminal phase elimination half-life (h) | 0.97 | 0.88 | Protein binding (%), mostly albumin | 97–99 | 95–97 | Side effect | Pain on injection and moderate to severe cardiovascular and respiratory depression | Transient perineal paresthesia, pruritus and mild cardiovascular and respiratory depression |
|
|